Severe feto-placental abnormalities precede the onset of hypertension and proteinuria in a mouse model of preeclampsia

Biology of Reproduction

Volumn 75, Issue 6, 2006, Pages 899-907

  Dokras, Anuja ^a   Hoffmann, Darren S ^a   Eastvold, Joshua S ^a   Kienzle, Martha F ^a   Gruman, Lynn M ^a   Kirby, Patricia A ^a   Weiss, Robert M ^a,b   Davisson, Robin L ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

Decidua; Gene regulation; Placenta; Pregnancy; Trophoblast

Indexed keywords

ACTIN; CELL MARKER; CYTOKERATIN; MESSENGER RNA; PROTEIN P57;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE FLUCTUATION; BORDERLINE HYPERTENSION; CELL LINEAGE; CELL STRUCTURE; CONTROLLED STUDY; DECIDUA; DOWN REGULATION; ELECTRON MICROSCOPY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; FETUS DISEASE; FETUS WEIGHT; GENE EXPRESSION; GESTATIONAL AGE; HYPERTENSION; MATERNAL DISEASE; MORPHOGENESIS; MOTHER FETUS RELATIONSHIP; MOUSE; MOUSE STRAIN; MOUSE STRAIN BPH 5; NONHUMAN; PLACENTA DISORDER; PLACENTA WEIGHT; PREECLAMPSIA; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; PULSE WAVE; SMOOTH MUSCLE FIBER; TROPHOBLAST; UTERINE ARTERY; VASCULAR RESISTANCE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FETAL WEIGHT; GENE EXPRESSION PROFILING; GESTATIONAL AGE; HYPERTENSION, PREGNANCY-INDUCED; MICE; MICE, INBRED C57BL; PLACENTA; PLACENTAL CIRCULATION; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA;

EID: 33751582927     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.106.053603     Document Type: Article

References (57)

1. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Births: final data for 2003. Natl Vital Stat Rep 2005; 54:1-116.
2. MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001; 97:533-538.
3. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 1992; 99:547-553.
4. Davisson RL, Hoffmann DS, Butz GM, Aldape G, Schlager G, Merrill DC, Sethi S, Weiss RM, Bates JN. Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension 2002; 39:337-342.
5. Sibai BM, Abdella TN, Anderson GD. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol 1983; 61:571-576.
6. Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, Goldenberg RL, Joffe G. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1997; 177:1003-1010.
7. Alexander BT, Kassab SE, Miller MT, Abram SR, Reckelhoff JF, Bennett WA, Granger JP. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 2000; 37:1191-1195.
8. Alexander BT, Cockrell KL, Massey MB, Bennett WA, Granger JP. Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. Am J Hypertens 2002; 15:170-175.
9. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993; 169:1316-1320.
10. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111:649-658.
11. Kanayama N, Takahashi K, Matsuura T, Sugimura M, Kobayashi T, Moniwa N, Tomita M, Nakayama K. Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol Hum Reprod 2002; 8:1129-1135.
12. Chun D, Braga C, Chow C, Lok L. Clinical observations on some aspects of hydatidiform moles. J Obstet Gynaecol Br Commonw 1964; 71:180-184.
13. Goldstein DP, Berkowitz RS. Current management of complete and partial molar pregnancy. J Reprod Med 1994; 39:139-146.
14. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1:177-191.
15. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003; 69:1-7.
16. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308:1592-1594.
17. Hirano H, Imai Y, Ito H. Spiral artery of placenta: development and pathology-immunohistochemical, microscopical, and electron-microscopic study. Kobe J Med Sci 2002; 48:13-23.
18. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997; 99:2152-2164.
19. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 1999; 103:1641-1650.
20. Redline RW, Patterson P. Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum Pathol 1995; 26:594-600.
21. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002; 160:1405-1423.
22. Roberts JM, Lain KY. Recent insights into the pathogenesis of preeclampsia. Placenta 2002; 23:359-372.
23. Rasmussen S, Irgens LM. Fetal growth and body proportion in preeclampsia. Obstet Gynecol 2003; 101:575-583.
24. Long PA, Abell DA, Beischer NA. Fetal growth retardation and preeclampsia. Br J Obstet Gynaecol 1980; 87:13-18.
25. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet 2001; 2:538-548.
26. Cross JC, Baczyk D, Dobric N, Hemberger M, Hughes M, Simmons DG, Yamamoto H, Kingdom JC. Genes, development and evolution of the placenta. Placenta 2003; 24:123-130.
27. Georgiades P, Ferguson-Smith AC, Burton GJ. Comparative developmental anatomy of the murine and human definitive placentae. Placenta 2002; 23:3-19.
28. Schlager G, Lester JW, Carrithers JA. Characteristics of the inbred hypertensive mouse strains. FASEB J 1989; 3:A1315.
29. Schlager G. Biometrical genetic analysis of blood pressure level in the genetically hypertensive mouse. Clin Exp Hypertens 1994; 16:809-824.
30. Schlager G. Genetic hypertension in mice. In: Ganten D, DeJong W, (eds.), Handbook of Hypertension. Amsterdam: Elsevier; 1994:158-172.
31. Lester JW. Survey of selected physiological properties of inbred hypertensive and hypotensive mice. Kansas, USA: University of Kansas; 1989. Thesis.
32. Laitinen L. Griffonia simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissues. Histochem J 1987; 19:225-234.
33. Takahashi K, Kobayashi T, Kanayama N. p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts. Mol Hum Reprod 2000; 6:1019-1025.
34. Vercruysse L, Caluwaerts S, Luyten C, Pijnenborg R. Interstitial trophoblast invasion in the decidua and mesometrial triangle during the last third of pregnancy in the rat. Placenta 2006; 27:22-33.
35. Croy BA, Ashkar AA, Minhas K, Greenwood JD. Can murine uterine natural killer cells give insights into the pathogenesis of preeclampsia? J Soc Gynecol Investig 2000; 7:12-20.
36. Georgiades P, Watkins M, Burton GJ, Ferguson-Smith AC. Roles for genomic imprinting and the zygotic genome in placental development. Proc Natl Acad Sci U S A 2001; 98:4522-4527.
37. Pijnenborg R, Robertson WB, Brosens I, Dixon G. Review article: trophoblast invasion and the establishment of haemochorial placentation in man and laboratory animals. Placenta 1981; 2:71-91.
38. Muntener M, Hsu YC. Development of trophoblast and placenta of the mouse. A reinvestigation with regard to the in vitro culture of mouse trophoblast and placenta. Acta Anat (Basel) 1977; 98:241-252.
39. Hemberger M, Cross JC, Ropers HH, Lehrach H, Fundele R, Himmelbauer H. UniGene cDNA array-based monitoring of transcriptome changes during mouse placental development. Proc Natl Acad Sci U S A 2001; 98:13126-13131.
40. Hill JA, Karimi M, Kutschke W, Davisson RL, Zimmerman K, Wang Z, Kerber RE, Weiss RM. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation 2000; 101:2863-2869.
41. Chaoui R, Hoffmann H, Bollmann R, Halle H, Zienert A, Metzner A. [Assessment of uteroplacental circulation in uncomplicated pregnancies using pulsed Doppler ultrasound]. Zentralbl Gynakol 1990; 112:11-18.
42. Adamson SL, Lu Y, Whiteley KJ, Holmyard D, Hemberger M, Pfarrer C, Cross JC. Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev Biol 2002; 250:358-373.
43. Mayhew TM. Thinning of the intervascular tissue layers of the human placenta is an adaptive response to passive diffusion in vivo and may help to predict the origins of fetal hypoxia. Eur J Obstet Gynecol Reprod Biol 1998; 81:101-109.
44. Parra M, Rodrigo R, Barja P, Bosco C, Fernandez V, Munoz H, Soto-Chacon E. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol 2005; 193:1486-1491.
45. Teasdale F. Histomorphometry of the human placenta in maternal preeclampsia. Am J Obstet Gynecol 1985; 152:25-31.
46. McMaster MT, Zhou Y, Fisher SJ. Abnormal placentation and the syndrome of preeclampsia. Semin Nephrol 2004; 24:540-547.
47. Carney EW, Prideaux V, Lye SJ, Rossant J. Progressive expression of trophoblast-specific genes during formation of mouse trophoblast giant cells in vitro. Mol Reprod Dev 1993; 34:357-368.
48. Linzer DI, Fisher SJ. The placenta and the prolactin family of hormones: regulation of the physiology of pregnancy. Mol Endocrinol 1999; 13:837-840.
49. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006; 27:939-958..
50. Carter AM, Enders AC, Jones CJ, Mess A, Pfarrer C, Pijnenborg R, Soma H. Comparative Placentation and animal models: patterns of trophoblast invasion - a workshop report. Placenta 2006; 27 Suppl A:530-533.
51. Cross JC. How to make a placenta: mechanisms of trophoblast cell differentiation in mice - a review. Placenta 2005; 26(suppl A):S3-S9.
52. Simmons DG, Cross JC. Determinants of trophoblast lineage and cell subtype specification in the mouse placenta. Dev Biol 2005; 284:12-24.
53. Jackson D, Volpert OV, Bouck N, Linzer DI. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein. Science 1994; 266:1581-1584.
54. Iwata M, Matsuzaki N, Shimizu I, Mitsuda N, Nakayama M, Suehara N. Prenatal detection of ischemic changes in the placenta of the growth-retarded fetus by Doppler flow velocimetry of the maternal uterine artery. Obstet Gynecol 1993; 82:494-499.
55. Abitbol MM, Gallo GR, Pirani CL, Ober WB. Production of experimental toxemia in the pregnant rabbit. Am J Obstet Gynecol 1976; 124:460-470.
56. Mayhew TM, Chamock-Jones DS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004; 25:127-139.
57. Cross JC, Simmons DG, Watson ED. Chorioallantoic morphogenesis and formation of the placental villous tree. Ann N Y Acad Sci 2003; 995:84-93.